Loading...

Jack Bui

Title(s)Professor, Pathology
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Bui studies how to initiate innate immune responses to cancer. His basic research lab uses mouse and human model systems to elucidate genes involved in tumor rejection. Dr. Bui also directs Clinical Flow Cytometry, Diagnostic Immunology, and Stem Cell Processing. His clinical interests include bone marrow transplantation, stem cell regeneration, and autoimmune disease.

    Collapse Research 
    Collapse Research Activities and Funding
    Elucidating the regulation and function of IL-17D using reporter mice
    NIH R21AI149023Mar 5, 2020 - Feb 28, 2022
    Role: Principal Investigator
    Innate anti-tumor immune responses
    NIH R01CA157885Aug 2, 2011 - May 31, 2017
    Role: Principal Investigator
    The function and regulation of histocompatibility antigen 60 in cancer
    NIH K08CA128893Aug 1, 2008 - Jul 31, 2014
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Elongated neutrophil-derived structures are blood-borne microparticles formed by rolling neutrophils during sepsis. J Exp Med. 2021 Mar 01; 218(3). Marki A, Buscher K, Lorenzini C, Meyer M, Saigusa R, Fan Z, Yeh YT, Hartmann N, Dan JM, Kiosses WB, Golden GJ, Ganesan R, Winkels H, Orecchioni M, McArdle S, Mikulski Z, Altman Y, Bui J, Kronenberg M, Chien S, Esko JD, Nizet V, Smalley D, Roth J, Ley K. PMID: 33275138.
      View in: PubMed   Mentions:    Fields:    
    2. Evaluation of IL-17D in Host Immunity to Group A Streptococcus Infection. J Immunol. 2020 Dec 01; 205(11):3122-3129. Washington A, Varki N, Valderrama JA, Nizet V, Bui JD. PMID: 33077643.
      View in: PubMed   Mentions:    Fields:    
    3. Heterogeneity and clonal relationships of adaptive immune cells in ulcerative colitis revealed by single-cell analyses. Sci Immunol. 2020 08 21; 5(50). Boland BS, He Z, Tsai MS, Olvera JG, Omilusik KD, Duong HG, Kim ES, Limary AE, Jin W, Milner JJ, Yu B, Patel SA, Louis TL, Tysl T, Kurd NS, Bortnick A, Quezada LK, Kanbar JN, Miralles A, Huylebroeck D, Valasek MA, Dulai PS, Singh S, Lu LF, Bui JD, Murre C, Sandborn WJ, Goldrath AW, Yeo GW, Chang JT. PMID: 32826341.
      View in: PubMed   Mentions: 3     Fields:    
    4. Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers. Cell. 2020 Aug 20; 182(4):1044-1061.e18. Hoshino A, Kim HS, Bojmar L, Gyan KE, Cioffi M, Hernandez J, Zambirinis CP, Rodrigues G, Molina H, Heissel S, Mark MT, Steiner L, Benito-Martin A, Lucotti S, Di Giannatale A, Offer K, Nakajima M, Williams C, Nogués L, Pelissier Vatter FA, Hashimoto A, Davies AE, Freitas D, Kenific CM, Ararso Y, Buehring W, Lauritzen P, Ogitani Y, Sugiura K, Takahashi N, Aleckovic M, Bailey KA, Jolissant JS, Wang H, Harris A, Schaeffer LM, García-Santos G, Posner Z, Balachandran VP, Khakoo Y, Raju GP, Scherz A, Sagi I, Scherz-Shouval R, Yarden Y, Oren M, Malladi M, Petriccione M, De Braganca KC, Donzelli M, Fischer C, Vitolano S, Wright GP, Ganshaw L, Marrano M, Ahmed A, DeStefano J, Danzer E, Roehrl MHA, Lacayo NJ, Vincent TC, Weiser MR, Brady MS, Meyers PA, Wexler LH, Ambati SR, Chou AJ, Slotkin EK, Modak S, Roberts SS, Basu EM, Diolaiti D, Krantz BA, Cardoso F, Simpson AL, Berger M, Rudin CM, Simeone DM, Jain M, Ghajar CM, Batra SK, Stanger BZ, Bui J, Brown KA, Rajasekhar VK, Healey JH, de Sousa M, Kramer K, Sheth S, Baisch J, Pascual V, Heaton TE, La Quaglia MP, Pisapia DJ, Schwartz R, Zhang H, Liu Y, Shukla A, Blavier L, DeClerck YA, LaBarge M, Bissell MJ, Caffrey TC, Grandgenett PM, Hollingsworth MA, Bromberg J, Costa-Silva B, Peinado H, Kang Y, Garcia BA, O'Reilly EM, Kelsen D, Trippett TM, Jones DR, Matei IR, Jarnagin WR, Lyden D. PMID: 32795414.
      View in: PubMed   Mentions: 21     Fields:    
    5. PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways. Immunity. 2019 12 17; 51(6):1059-1073.e9. Zhao Y, Lee CK, Lin CH, Gassen RB, Xu X, Huang Z, Xiao C, Bonorino C, Lu LF, Bui JD, Hui E. PMID: 31757674.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    6. Machine Learning of Discriminative Gate Locations for Clinical Diagnosis. Cytometry A. 2020 03; 97(3):296-307. Ji D, Putzel P, Qian Y, Chang I, Mandava A, Scheuermann RH, Bui JD, Wang HY, Smyth P. PMID: 31691488.
      View in: PubMed   Mentions:    Fields:    
    7. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor. Cancer Res. 2019 04 15; 79(8):1996-2008. Yokoyama Y, Lew ED, Seelige R, Tindall EA, Walsh C, Fagan PC, Lee JY, Nevarez R, Oh J, Tucker KD, Chen M, Diliberto A, Vaaler H, Smith KM, Albert A, Li G, Bui JD. PMID: 30723115.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    8. Identification and editing of stem-like cells in methylcholanthrene-induced sarcomas. Oncoimmunology. 2019; 8(1):e1404212. Gross ETE, Peinado CD, Jung Y, Han S, Liu B, Santosa EK, Bui JD. PMID: 30546937.
      View in: PubMed   Mentions:
    9. Siglec-7 engagement by GBS ß-protein suppresses pyroptotic cell death of natural killer cells. Proc Natl Acad Sci U S A. 2018 10 09; 115(41):10410-10415. Fong JJ, Tsai CM, Saha S, Nizet V, Varki A, Bui JD. PMID: 30254166.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    10. Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection. Sci Rep. 2018 09 12; 8(1):13670. Seelige R, Saddawi-Konefka R, Adams NM, Picarda G, Sun JC, Benedict CA, Bui JD. PMID: 30209334.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    11. Isoflurane Impacts Murine Melanoma Growth in a Sex-Specific, Immune-Dependent Manner: A Brief Report. Anesth Analg. 2018 06; 126(6):1910-1913. Meier A, Gross ETE, Schilling JM, Seelige R, Jung Y, Santosa E, Searles S, Lin T, Tu XM, Patel HH, Bui JD. PMID: 29570154.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    12. Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs. Sci Transl Med. 2018 05 09; 10(440). Strnadel J, Carromeu C, Bardy C, Navarro M, Platoshyn O, Glud AN, Marsala S, Kafka J, Miyanohara A, Kato T, Tadokoro T, Hefferan MP, Kamizato K, Yoshizumi T, Juhas S, Juhasova J, Ho CS, Kheradmand T, Chen P, Bohaciakova D, Hruska-Plochan M, Todd AJ, Driscoll SP, Glenn TD, Pfaff SL, Klima J, Ciacci J, Curtis E, Gage FH, Bui J, Yamada K, Muotri AR, Marsala M. PMID: 29743351.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    13. Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance. J Immunol. 2018 06 15; 200(12):4012-4023. Klann JE, Kim SH, Remedios KA, He Z, Metz PJ, Lopez J, Tysl T, Olvera JG, Ablack JN, Cantor JM, Boland BS, Yeo G, Zheng Y, Lu LF, Bui JD, Ginsberg MH, Petrich BG, Chang JT. PMID: 29703862.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    14. Cell-cell fusion as a mechanism of DNA exchange in cancer. Oncotarget. 2018 Jan 19; 9(5):6156-6173. Searles SC, Santosa EK, Bui JD. PMID: 29464062.
      View in: PubMed   Mentions: 7     Fields:    
    15. Automated Analysis of Clinical Flow Cytometry Data: A Chronic Lymphocytic Leukemia Illustration. Clin Lab Med. 2017 12; 37(4):931-944. Scheuermann RH, Bui J, Wang HY, Qian Y. PMID: 29128077.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. The Next Frontier: Head and Neck Cancer Immunoprevention. Cancer Prev Res (Phila). 2017 Dec; 10(12):681-683. Gutkind JS, Bui JD. PMID: 29138137.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    17. Innate sensing of cancer's non-immunologic hallmarks. Curr Opin Immunol. 2018 02; 50:1-8. Seelige R, Searles S, Bui JD. PMID: 29032295.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    18. Proteasome activity regulates CD8+ T lymphocyte metabolism and fate specification. J Clin Invest. 2017 Oct 02; 127(10):3609-3623. Widjaja CE, Olvera JG, Metz PJ, Phan AT, Savas JN, de Bruin G, Leestemaker Y, Berkers CR, de Jong A, Florea BI, Fisch K, Lopez J, Kim SH, Garcia DA, Searles S, Bui JD, Chang AN, Yates JR, Goldrath AW, Overkleeft HS, Ovaa H, Chang JT. PMID: 28846070.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    19. Mechanisms regulating immune surveillance of cellular stress in cancer. Cell Mol Life Sci. 2018 01; 75(2):225-240. Seelige R, Searles S, Bui JD. PMID: 28744671.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    20. eIF5A-PEAK1 Signaling Regulates YAP1/TAZ Protein Expression and Pancreatic Cancer Cell Growth. Cancer Res. 2017 04 15; 77(8):1997-2007. Strnadel J, Choi S, Fujimura K, Wang H, Zhang W, Wyse M, Wright T, Gross E, Peinado C, Park HW, Bui J, Kelber J, Bouvet M, Guan KL, Klemke RL. PMID: 28381547.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    21. Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells. Biol Blood Marrow Transplant. 2017 Apr; 23(4):625-634. Chen YB, Efebera YA, Johnston L, Ball ED, Avigan D, Lekakis LJ, Bachier CR, Martin P, Duramad O, Ishii Y, Han S, Jung YJ, Lee D, Kunkel L, Negrin RS, Bui JD. PMID: 28104514.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCellsCTClinical Trials
    22. Immunosurveillance and immunoediting in MMTV-PyMT-induced mammary oncogenesis. Oncoimmunology. 2017; 6(2):e1268310. Gross ET, Han S, Vemu P, Peinado CD, Marsala M, Ellies LG, Bui JD. PMID: 28344881.
      View in: PubMed   Mentions:
    23. The ancient cytokine IL-17D is regulated by Nrf2 and mediates tumor and virus surveillance. Cytokine. 2017 03; 91:10-12. Seelige R, Washington A, Bui JD. PMID: 27940089.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    24. Nrf2 Induces IL-17D to Mediate Tumor and Virus Surveillance. Cell Rep. 2016 08 30; 16(9):2348-58. Saddawi-Konefka R, Seelige R, Gross ET, Levy E, Searles SC, Washington A, Santosa EK, Liu B, O'Sullivan TE, Harismendy O, Bui JD. PMID: 27545889.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    25. Molecular Programming of Tumor-Infiltrating CD8+ T Cells and IL15 Resistance. Cancer Immunol Res. 2016 09 02; 4(9):799-811. Doedens AL, Rubinstein MP, Gross ET, Best JA, Craig DH, Baker MK, Cole DJ, Bui JD, Goldrath AW. PMID: 27485135.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    26. Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition. Oncotarget. 2016 Apr 19; 7(16):21527-41. Banno A, Garcia DA, van Baarsel ED, Metz PJ, Fisch K, Widjaja CE, Kim SH, Lopez J, Chang AN, Geurink PP, Florea BI, Overkleeft HS, Ovaa H, Bui JD, Yang J, Chang JT. PMID: 26930717.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    27. Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 2015 Dec 01; 6(38):41204-15. Bloy N, Sauvat A, Chaba K, Buqué A, Humeau J, Bravo-San Pedro JM, Bui J, Kepp O, Kroemer G, Senovilla L. PMID: 26517677.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    28. Immunodeficiency and autoimmune enterocolopathy linked to NFAT5 haploinsufficiency. J Immunol. 2015 Mar 15; 194(6):2551-60. Boland BS, Widjaja CE, Banno A, Zhang B, Kim SH, Stoven S, Peterson MR, Jones MC, Su HI, Crowe SE, Bui JD, Ho SB, Okugawa Y, Goel A, Marietta EV, Khosroheidari M, Jepsen K, Aramburu J, López-Rodríguez C, Sandborn WJ, Murray JA, Harismendy O, Chang JT. PMID: 25667416.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    29. Drak2 is not required for tumor surveillance and suppression. Int Immunol. 2015 Mar; 27(3):161-6. Edwards BA, Harris TL, Floersh H, Lukens JR, Zaki MH, Vogel P, Kanneganti TD, Bui JD, McGargill MA. PMID: 25568303.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    30. Tumor-expressed IL-17D recruits NK cells to reject tumors. Oncoimmunology. 2014 12; 3(12):e954853. Saddawi-Konefka R, O'Sullivan T, Gross ET, Washington A, Bui JD. PMID: 25964859.
      View in: PubMed   Mentions:
    31. uPAR induces expression of transforming growth factor ß and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophages. Am J Pathol. 2014 Dec; 184(12):3384-93. PMID: 25310970.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    32. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc Natl Acad Sci U S A. 2014 Sep 30; 111(39):14211-6. Läubli H, Pearce OM, Schwarz F, Siddiqui SS, Deng L, Stanczak MA, Deng L, Verhagen A, Secrest P, Lusk C, Schwartz AG, Varki NM, Bui JD, Varki A. PMID: 25225409.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimalsCells
    33. Hormesis in cancer immunology: Does the quantity of an immune reactant matter? Oncoimmunology. 2014; 3:e29312. Pearce OM, Läubli H, Bui J, Varki A. PMID: 25083340.
      View in: PubMed   Mentions:
    34. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 2014 May 22; 7(4):989-98. PMID: 24794441.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    35. Pig models of neurodegenerative disorders: Utilization in cell replacement-based preclinical safety and efficacy studies. J Comp Neurol. 2014 Aug 15; 522(12):2784-801. PMID: 24610493.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimals
    36. Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc Natl Acad Sci U S A. 2014 Apr 22; 111(16):5998-6003. PMID: 24711415.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    37. Cancer immunosurveillance and immunoediting by natural killer cells. Cancer J. 2013 Nov-Dec; 19(6):483-9. PMID: 24270347.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    38. Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A. 2013 Jul 23; 110(30):12391-6. PMID: 23836658.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    39. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners. Biotechnol Bioeng. 2013 Nov; 110(11):2826-35. PMID: 23719862.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCells
    40. Effective long-term immunosuppression in rats by subcutaneously implanted sustained-release tacrolimus pellet: effect on spinally grafted human neural precursor survival. Exp Neurol. 2013 Oct; 248:85-99. PMID: 23748136.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    41. The nuclear factor-?B pathway down-regulates expression of the NKG2D ligand H60a in vitro: implications for use of nuclear factor-?B inhibitors in cancer therapy. Immunology. 2013 Jun; 139(2):265-74. Peinado C, Kang X, Hardamon C, Arora S, Mah S, Zhang H, Ngolab J, Bui JD. PMID: 23350962.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    42. Production of unique immunotoxin cancer therapeutics in algal chloroplasts. Proc Natl Acad Sci U S A. 2013 Jan 02; 110(1):E15-22. PMID: 23236148.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansAnimalsCells
    43. Cancer immunoediting by the innate immune system in the absence of adaptive immunity. J Exp Med. 2012 Sep 24; 209(10):1869-82. PMID: 22927549.
      View in: PubMed   Mentions: 114     Fields:    Translation:AnimalsCells
    44. A dual function of NKG2D ligands in NK-cell activation. Eur J Immunol. 2012 Sep; 42(9):2452-8. PMID: 22740149.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    45. Strain-specific variation in murine natural killer gene complex contributes to differences in immunosurveillance for urethane-induced lung cancer. Cancer Res. 2012 Sep 01; 72(17):4311-7. PMID: 22751136.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    46. Specific inactivation of two immunomodulatory SIGLEC genes during human evolution. Proc Natl Acad Sci U S A. 2012 Jun 19; 109(25):9935-40. PMID: 22665810.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimals
    47. The clinical implications of antitumor immunity in head and neck cancer. Laryngoscope. 2012 Jan; 122(1):144-57. PMID: 22183634.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    48. ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res. 2012 Jan 01; 72(1):365-74. PMID: 22086849.
      View in: PubMed   Mentions: 61     Fields:    Translation:AnimalsCells
    49. Cancer immunoediting of the NK group 2D ligand H60a. J Immunol. 2011 Oct 01; 187(7):3538-45. PMID: 21876033.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    50. The unique pathophysiology of early-onset severe preeclampsia: role of decidual T regulatory cells. J Reprod Immunol. 2011 Sep; 91(1-2):76-82. PMID: 21782252.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    51. Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. Glycobiology. 2011 Aug; 21(8):1038-48. Wang X, Chow R, Deng L, Anderson D, Weidner N, Godwin AK, Bewtra C, Zlotnik A, Bui J, Varki A, Varki N. PMID: 21467073.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    52. Studies on the antigenicity of the NKG2D ligand H60a in tumour cells. Immunology. 2011 Jun; 133(2):197-205. Yadav D, Ngolab J, Dang N, Bui JD. PMID: 21438873.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    53. Studies of the H60a locus in C57BL/6 and 129/Sv mouse strains identify the H60a 3'UTR as a regulator of H60a expression. Mol Immunol. 2011 Jan; 48(4):539-45. Zhang H, Hardamon C, Sagoe B, Ngolab J, Bui JD. PMID: 21093919.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    54. The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth. J Immunol. 2010 Jan 01; 184(1):369-78. Büchau AS, Morizane S, Trowbridge J, Schauber J, Kotol P, Bui JD, Gallo RL. PMID: 19949065.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansAnimalsCells
    55. Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-gamma-induced microRNA. J Immunol. 2009 Jan 01; 182(1):39-43. Yadav D, Ngolab J, Lim RS, Krishnamurthy S, Bui JD. PMID: 19109132.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    56. Prolongation of cardiac and islet allograft survival by a blocking hamster anti-mouse CXCR3 monoclonal antibody. Transplantation. 2008 Jul 15; 86(1):137-47. Uppaluri R, Sheehan KC, Wang L, Bui JD, Brotman JJ, Lu B, Gerard C, Hancock WW, Schreiber RD. PMID: 18622291.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    57. Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes? Curr Opin Immunol. 2007 Apr; 19(2):203-8. Bui JD, Schreiber RD. PMID: 17292599.
      View in: PubMed   Mentions: 100     Fields:    Translation:Animals
    58. Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins. Cancer Res. 2006 Jul 15; 66(14):7301-9. Bui JD, Uppaluri R, Hsieh CS, Schreiber RD. PMID: 16849580.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    59. IFN-dependent down-regulation of the NKG2D ligand H60 on tumors. J Immunol. 2006 Jan 15; 176(2):905-13. Bui JD, Carayannopoulos LN, Lanier LL, Yokoyama WM, Schreiber RD. PMID: 16393975.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    60. Active Ca2+/calmodulin-dependent protein kinase II gamma B impairs positive selection of T cells by modulating TCR signaling. J Immunol. 2005 Jul 15; 175(2):656-64. McGargill MA, Sharp LL, Bui JD, Hedrick SM, Calbo S. PMID: 16002660.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    61. A critical function for type I interferons in cancer immunoediting. Nat Immunol. 2005 Jul; 6(7):722-9. Dunn GP, Bruce AT, Sheehan KC, Shankaran V, Uppaluri R, Bui JD, Diamond MS, Koebel CM, Arthur C, White JM, Schreiber RD. PMID: 15951814.
      View in: PubMed   Mentions: 180     Fields:    Translation:Animals
    62. Interferon-gamma and cancer immunoediting. Immunol Res. 2005; 32(1-3):231-45. Dunn GP, Ikeda H, Bruce AT, Koebel C, Uppaluri R, Bui J, Chan R, Diamond M, White JM, Sheehan KC, Schreiber RD. PMID: 16106075.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    63. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII. J Thorac Cardiovasc Surg. 2002 Oct; 124(4):852-4. Bui JD, Despotis GD, Trulock EP, Patterson GA, Goodnough LT. PMID: 12324751.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans